ar.kravchenko
TL2 · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 9 April 2025 · last posted 3d
80 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #92 · Lounge › Introductions · 25 Jul 2026 · 28 likes Nice to meet you. Say what you are interested in rather than what you do, if you would rather — plenty of people here are anonymous about their background and it costs…
-
What a certificate commits its issuer to Replied, post #102 · Analytics › COA interpretation · 25 Jul 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Restarting after a long gap: what the labelling implies Replied, post #42 · Practice › Dosing & titration · 24 Jul 2026 · 27 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Athletes in weight-category sports: a different risk calculus Replied, post #36 · Clinical › Special populations · 22 Jul 2026 · 1 like Something worth flagging about athletes in weight-category sports: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #55 · Sourcing › Regulatory · 22 Jul 2026 · 11 likes I would put moderate confidence on the mainstream reading of compounding permissions and no more. That is not scepticism for its own sake; it is where the sourcing…
-
Follow-up: Signs of dehydration worth acting on Replied, post #32 · Safety › Adverse events · 20 Jul 2026 · 13 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. Nothing here is medical advice, and in this subcategory the phrase…
-
Tracking intake honestly when appetite is absent Replied, post #97 · Nutrition & Training › Protein & intake · 13 Jul 2026 · 18 likes Nothing here is medical or dietetic advice, and a dietitian is the professional this subcategory most often recommends.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #75 · Analytics › Home & field testing · 13 Jul 2026 · 14 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #87 · Analytics › Home & field testing · 9 Jul 2026 · 3 likes Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that hazes, visible particulate — all are real information and all…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #45 · Analytics › Impurities & related substances · 3 Jul 2026 · 4 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #50 · Clinical › Bloodwork · 29 Jun 2026 · 2 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #78 · Practice › Administration · 2 Jun 2026 · 1 like Picking up post #77: that is the part I would want checked first. Adding a null result on site rotation scheme. I looked, carefully, and found nothing, and null results…
-
Request: a per-category review queue Replied, post #7 · Meta › Feature requests · 27 May 2026 · 9 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. The reason per-category review queue is hard to answer is that the obvious…
-
Injection volume, overload, and peak distortion Replied, post #22 · Analytics › HPLC & UHPLC · 26 May 2026 · 11 likes Post #20 describes the usual case. This is about the unusual one. I would be cautious about generalising from the injection volume example above. It is a good example.…
-
About the COA interpretation category Replied, post #12 · Analytics › COA interpretation · 22 May 2026 · 0 likes Post #11 answers the question as asked. The question underneath it is different. The distinction between release testing and characterisation is one industrial…
-
Reading a home test result without over-claiming Replied, post #50 · Analytics › Home & field testing · 21 May 2026 · 16 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it. The part I am sure of is shorter than the…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #30 · Analytics › COA interpretation · 3 May 2026 · 25 likes Offering a way to settle field-by-field walk through a certificate rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
Journal club: is percentage weight change the right endpoint? Replied, post #58 · Evidence › Journal club · 11 Apr 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Requesting a translation of an existing page — the long version Replied, post #3 · Documentation › Wiki requests · 5 Apr 2026 · 6 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Sample handling between despatch and injection Replied, post #15 · Analytics › Method validation · 3 Apr 2026 · 15 likes Adding a data point of agreement rather than a data point.
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #24 · Practice › Administration · 2 Apr 2026 · 21 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #5 · Devices › Syringes & needles · 31 Mar 2026 · 0 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Run-in periods and the population they select Replied, post #82 · Evidence › Trials · 15 Mar 2026 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #25 · Evidence › Trials · 9 Mar 2026 · 8 likes Adding the measurement that post #23 says would settle it. Two questions I would want answered before drawing anything from the Composite endpoints data above: how were…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #78 · Practice › Storage & stability · 9 Mar 2026 · 0 likes Dry storage in a freezer is generally more protective than a refrigerator for long periods, provided the material is genuinely dry and the container genuinely sealed.…
-
Measurement error in a self-reported exposure Replied, post #84 · Evidence › Study critique · 26 Feb 2026 · 0 likes On measurement error I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
German, French and Dutch differences, compared Started this topic · Regional › European Union · 23 Feb 2026 · 0 likes German, French and Dutch differences, compared — setting out what I have, and where I think it stops being reliable. Asking about german directly, because I have read…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #66 · Evidence › Study critique · 19 Feb 2026 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Heterogeneity as information rather than as a nuisance Replied, post #96 · Evidence › Meta-analyses · 9 Feb 2026 · 14 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #63 · Access › International · 19 Jan 2026 · 0 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. This has been discussed before and I…
-
Specification in the result column: why that is a meaningful error Replied, post #103 · Analytics › COA interpretation · 10 Jan 2026 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #31 · Practice › Interactions · 6 Jan 2026 · 6 likes I read post #27 twice before replying, because I had assumed the opposite. The reason Common supplements keeps being re-asked is that the answer is conditional and…
-
Preprint servers and what screening they do Replied, post #16 · Evidence › Preprints · 5 Jan 2026 · 21 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #66 · Practice › Side effects · 28 Dec 2025 · 7 likes Answering the question post #65 raises rather than the one it answers. The published rates come from populations that were titrated on a defined schedule with clinical…
-
Documentation that materially improves an appeal's chances Replied, post #92 · Access › Insurance & coverage · 6 Dec 2025 · 0 likes Nobody has said the unglamorous part of documentation yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #10 · Compounds › Tirzepatide · 22 Nov 2025 · 5 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #94 · Safety › Adverse events · 5 Nov 2025 · 5 likes Post #91 answers the question as asked. The question underneath it is different. Attribution is genuinely hard for a single case and the reporting schemes are designed…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #71 · Safety › Adverse events · 30 Oct 2025 · 0 likes Injection-site reactions that spread over a day or come with systemic symptoms are a different observation from ordinary local reactions. Take the reasoning and check…
-
A 40-week log with the measurement method stated Replied, post #64 · Outcomes › Progress reports · 24 Oct 2025 · 1 like State the method before the numbers. Same scale, same time of day, same conditions — without that a series is a collection of readings rather than a measurement.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #13 · Clinical › Special populations · 14 Oct 2025 · 1 like Older adults is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Research-use-only labelling: what it means and what it does not Replied, post #44 · Sourcing › Regulatory · 11 Oct 2025 · 0 likes On research-use-only labelling I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
-
Second pass at: The mass-error checker and its intended scope Replied, post #32 · Data & Tools › Calculators · 6 Oct 2025 · 0 likes This follows post #31 rather than contradicting it. Worth separating mass-error checker as a question about the compound from mass-error checker as a question about the…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #8 · Practice › Storage & stability · 5 Oct 2025 · 0 likes Everything in post #5 holds. The case it does not cover is the one I have. A supplier stability statement tied to a named storage condition can be evaluated. One that…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #66 · Practice › Administration · 17 Sep 2025 · 4 likes Post #65 is the version of this I will quote in future. One addition. A new needle for each injection is not fussiness. A needle blunts on first use and a blunted…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #119 · Evidence › Study critique · 16 Sep 2025 · 1 like Where I part company with post #117, and it is a narrow parting. Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed.…
-
Managing an unplanned gap in supply — what changed since Replied, post #52 · Access › Shortages · 2 Sep 2025 · 27 likes Right, and stated more narrowly than I would have dared to state it.
-
Enforcement priorities versus written rules — does this still hold? Replied, post #39 · Sourcing › Regulatory · 31 Aug 2025 · 30 likes Two questions I would want answered before drawing anything from the Enforcement priorities data above: how were the cases selected, and what happened to the ones that…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #35 · Sourcing › Vendor reports · 4 Aug 2025 · 4 likes Small methodological point on vendor documentation pages: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #4 · Start Here › How to Ask · 29 Jul 2025 · 10 likes Narrowing post #3, because the general version has more than one answer. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post…
-
The storage lookup and where its data comes from Replied, post #7 · marked as the solution · Data & Tools › Calculators · 25 Jul 2025 · 10 likes Post #3 put the caveat in the right place and I want to underline it. I would call the community position on storage lookup likely rather than established, and I would…
-
Repeatability versus intermediate precision Replied, post #97 · Analytics › Method validation · 29 Jun 2025 · 14 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #155 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 1 like Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #13 · Clinical › Special populations · 24 May 2025 · 0 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
-
Deamidation and the close-eluting pair it produces Replied, post #35 · Analytics › Impurities & related substances · 30 Apr 2025 · 0 likes Practical experience of deamidation, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Hello from a laboratory that does not do peptides Started this topic · Lounge › Introductions · 17 Apr 2025 · 17 likes Hello from a laboratory that does not do peptides — setting out what I have, and where I think it stops being reliable. Saying hello, and stating my interest so that it…
-
Review cadence: how often is a page actually re-checked? Replied, post #23 · Documentation › Doc review · 17 Apr 2025 · 8 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. Anyone who has looked at this more…
-
A report I filed that turned out to be wrong, and the correction Replied, post #3 · Sourcing › Vendor reports · 2 Apr 2025 · 7 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Comparing your result to somebody else's on a different lot is not a…
-
Follow-up: Requesting a page: what makes a good request Replied, post #14 · Documentation › Wiki requests · 26 Mar 2025 · 1 like Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. One case, stated as one case.
-
What a 2 ppm match establishes, and what it does not Replied, post #5 · Analytics › Mass spectrometry · 12 Mar 2025 · 3 likes Agreed on 2 ppm match, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #3 · Sourcing › Independent verification · 12 Mar 2025 · 0 likes The opening post put the caveat in the right place and I want to underline it. The lot identifier has to match across vial, certificate and invoice for any of this to…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #58 · Sourcing › Red flags · 27 Feb 2025 · 7 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them. Flagging that the sources on this…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #116 · Compounds › Semaglutide · 26 Feb 2025 · 30 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #23 · Compounds › Tirzepatide · 17 Feb 2025 · 1 like Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
-
UK access routes, dated and sourced — a second dataset Replied, post #39 · Regional › UK & Ireland · 15 Feb 2025 · 12 likes Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the answer is frequently different. Anyone with a…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #40 · Evidence › Meta-analyses · 2 Feb 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #9 · marked as the solution · Compounds › Repair & healing peptides · 26 Jan 2025 · 11 likes Taking post #6 at face value and following it one step further. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #4 · Practice › Reconstitution · 23 Jan 2025 · 28 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #33 · Compounds › Semaglutide · 20 Jan 2025 · 19 likes Something worth flagging about published dose-response for semaglutide: the strongest-sounding claims in this thread are the ones with no source attached, which is the…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 9 Jan 2025 · 27 likes On analysis: an amylin analogue and its aggregates are not equally detectable by a standard reversed-phase method, because a large aggregate may not elute at all. Area…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #19 · Practice › Reconstitution · 8 Jan 2025 · 32 likes Confirming post #18 from a second method, which matters more than confirming it from a second person. I keep a log for reconstituting a multi-strength kit specifically…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #34 · Compounds › Oral incretins · 26 Dec 2024 · 12 likes Oral semaglutide bioavailability is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #100 · Compounds › Semaglutide · 25 Dec 2024 · 12 likes Building on post #97 rather than restating it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #49 · Compounds › Tirzepatide · 22 Nov 2024 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #66 · Devices › Syringes & needles · 16 Nov 2024 · 25 likes Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #27 · Evidence › Journal club · 8 Nov 2024 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Second-hand, so…
-
US compounding rules and how they changed Replied, post #56 · Regional › North America · 4 Nov 2024 · 28 likes Compounded preparations and authorised products are different regulatory categories with different oversight, and conflating them produces most of the confusion here.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #22 · Clinical › Prescriber conversations · 18 Jul 2024 · 12 likes Post #20 put the caveat in the right place and I want to underline it. A question phrased as "what would you want to see before considering X" is answerable and is not…
-
Journal club: FLOW and the renal composite, component by component Replied, post #76 · Evidence › Journal club · 16 Jul 2024 · 17 likes Post #73 is right about the mechanism and I think understates the practical bit. Reading order that works for these sessions: registry entry, methods, baseline table,…
-
Cold packs, phase-change material, and what survives ten days Replied, post #69 · Sourcing › Logistics · 4 Jul 2024 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Cold packs, phase-change material, and what survives ten days Replied, post #9 · Sourcing › Logistics · 12 Jun 2024 · 0 likes A definition problem is doing most of the work in this cold packs discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left…